{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:14:48Z","timestamp":1777900488267,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006518","name":"UNIVERSITY OF NEBRASKA MEDICAL CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.gore.2026.102067","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:02:07Z","timestamp":1774584127000},"page":"102067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Consideration for HPV vaccination recommendations in patients with vulvar dysplasia and malignancy following resection: A retrospective study investigating rural-urban vaccination practices in patients served by an academic medical center in the heartland"],"prefix":"10.1016","volume":"64","author":[{"given":"Zoe","family":"Keese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaeli","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Ortiz Barragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-6774","authenticated-orcid":false,"given":"Lindsey A.","family":"McAlarnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2026.102067_b0005","unstructured":"Centers for Disease Control and Prevention. Reasons to get vaccinated [Internet]. Atlanta (GA): CDC; 2024 Jul 3 [cited 2025 Oct 8]. Available from: https:\/\/www.cdc.gov\/hpv\/vaccines\/reasons-to-get.html."},{"issue":"5","key":"10.1016\/j.gore.2026.102067_b0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: a systematic review and meta-analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2026.102067_b0015","doi-asserted-by":"crossref","unstructured":"Bartels HC, Postle J, Rogers AC, Brennan D. Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis. Int J Gynecol Cancer. 2020 Jun;30(6):777-782. doi: 10.1136\/ijgc-2020-001197. Epub 2020 Apr 9. Erratum in: Int J Gynecol Cancer. 2020 Jul;30(7):1085-1086. doi: 10.1136\/ijgc-2020-001197corr1. PMID: 32276936.","DOI":"10.1136\/ijgc-2020-001197"},{"key":"10.1016\/j.gore.2026.102067_b0020","series-title":"Adjuvant human papillomavirus vaccination for patients undergoing treatment for cervical intraepithelial neoplasia [practice advisory]","author":"American College of Obstetricians and Gynecologists","year":"2023"},{"key":"10.1016\/j.gore.2026.102067_b0025","doi-asserted-by":"crossref","unstructured":"Sharpless KE, Marcus JZ, Kuroki LM, Wiser AL, Flowers L. ASCCP committee opinion: adjuvant human papillomavirus vaccine for patients undergoing treatment for cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2023 Jan 1;27(1):93-96. doi: 10.1097\/LGT.0000000000000703. Epub 2022 Oct 21. PMID: 36538783; PMCID: PMC9770105.","DOI":"10.1097\/LGT.0000000000000703"},{"issue":"9","key":"10.1016\/j.gore.2026.102067_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204162","article-title":"Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.gore.2026.102067_b0035","unstructured":"Ayala M, Fatehi M. Vulvar Intraepithelial Neoplasia. [Updated 2023 Oct 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK540982\/?."},{"key":"10.1016\/j.gore.2026.102067_b0040","doi-asserted-by":"crossref","unstructured":"Mix JM, Gopalani SV, Simko S, Saraiya M. Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001-2017. Prev Med. 2022 Nov;164:107302. doi: 10.1016\/j.ypmed.2022.107302. Epub 2022 Oct 12. PMID: 36240909; PMCID: PMC10999169.","DOI":"10.1016\/j.ypmed.2022.107302"},{"issue":"2","key":"10.1016\/j.gore.2026.102067_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/vaccines9020083","article-title":"Surgical treatment of vulvar HSIL: adjuvant HPV vaccine reduces recurrent disease","volume":"9","author":"Ghelardi","year":"2021","journal-title":"Vaccines (basel)."},{"issue":"8","key":"10.1016\/j.gore.2026.102067_b0050","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-24-0072","article-title":"Rural-Urban cancer incidence and trends in the United States, 2000 to 2019","volume":"33","author":"Semprini","year":"2024","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.gore.2026.102067_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/jrh.12915","article-title":"What cancers explain the growing rural-urban gap in human papillomavirus-associated cancer incidence?","volume":"41","author":"Semprini","year":"2025","journal-title":"J. Rural Health"},{"issue":"2","key":"10.1016\/j.gore.2026.102067_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jrh.12305","article-title":"Rural-Urban differences in human papillomavirus-associated cancer trends and rates","volume":"35","author":"Zahnd","year":"2019","journal-title":"J. Rural Health"},{"issue":"1","key":"10.1016\/j.gore.2026.102067_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12905-018-0707-9","article-title":"HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review","volume":"19","author":"Bryan","year":"2019","journal-title":"BMC Womens Health"},{"issue":"4","key":"10.1016\/j.gore.2026.102067_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0819","article-title":"Effect of human papillomavirus vaccine to interrupt recurrence of vulvar and anal neoplasia (VIVA): a trial protocol","volume":"2","author":"Stankiewicz Karita","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.gore.2026.102067_b0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2025.07.029","article-title":"Health equity, disparities, and barriers to cervical cancer care in the U.S.: a consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment","volume":"200","author":"Neibart","year":"2025","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:31:06Z","timestamp":1777631466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"alternative-id":["S2352578926000470"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102067","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consideration for HPV vaccination recommendations in patients with vulvar dysplasia and malignancy following resection: A retrospective study investigating rural-urban vaccination practices in patients served by an academic medical center in the heartland","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102067"}}